FDA Clears Finesse Injectable “Gen 2”
Expanded Multifunctional Angioplasty Catheter Product Line for BTK Procedures CAMBRIDGE, Massachusetts, July 17, 2024— Summa Therapeutics, a specialty angioplasty balloon medical device company, announced today that “Gen 2” of Summa’s revolutionary Finesse InjectableTM angioplasty balloon catheters has been cleared by the FDA for PTA treatment of peripheral artery disease including, among others, infra-popliteal (“below-the-knee”) arteries.…
Read more
